Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration

Ke Lin; Janet Adamson; Gillian G Johnson; Anthony Carter; Melanie Oates; Rachel Wade; Sue Richards; David Gonzalez; Estella Matutes; Claire Dearden; David G Oscier; Daniel Catovsky; Andrew R Pettitt

doi:10.1158/1078-0432.CCR-11-2936

Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration

Ke Lin
, Janet Adamson
, Gillian G Johnson
, Anthony Carter
, Melanie Oates
, Rachel Wade
, Sue Richards
, David Gonzalez
, Estella Matutes
, Claire Dearden
, David G Oscier
, Daniel Catovsky
, Andrew R Pettitt

Résultats de recherche: Article › Revue par des pairs

30 Citations (Scopus)

Résumé

This study sought to establish whether functional analysis of the ATM-p53-p21 pathway adds to the information provided by currently available prognostic factors in patients with chronic lymphocytic leukemia (CLL) requiring frontline chemotherapy.

langue originale	English
Pages (de - à)	4191-200
Nombre de pages	10
journal	Clinical Cancer Research : An Official Journal of the American Association for Cancer Research
Volume	18
Numéro de publication	15
Les DOIs	https://doi.org/10.1158/1078-0432.CCR-11-2936
état	Published - 1 août 2012

SDG des Nations Unies

Ce résultat contribue à ou aux Objectifs de développement durable suivants

Good health and well being

Accès au document

10.1158/1078-0432.CCR-11-2936

Contient cette citation

Lin, K., Adamson, J., Johnson, G. G., Carter, A., Oates, M., Wade, R., Richards, S., Gonzalez, D., Matutes, E., Dearden, C., Oscier, D. G., Catovsky, D., & Pettitt, A. R. (2012). Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(15), 4191-200. https://doi.org/10.1158/1078-0432.CCR-11-2936

@article{c0465841cf62405ea460329b8616725a,

title = "Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration",

abstract = "This study sought to establish whether functional analysis of the ATM-p53-p21 pathway adds to the information provided by currently available prognostic factors in patients with chronic lymphocytic leukemia (CLL) requiring frontline chemotherapy.",

keywords = "Aged, Antineoplastic Combined Chemotherapy Protocols, Ataxia Telangiectasia Mutated Proteins, Cell Cycle Proteins, Chlorambucil, Cyclin-Dependent Kinase Inhibitor p21, Cyclophosphamide, DNA-Binding Proteins, Female, Flow Cytometry, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Leukocytes, Mononuclear, Male, Middle Aged, Mutation, Prognosis, Protein-Serine-Threonine Kinases, Randomized Controlled Trials as Topic, Signal Transduction, Survival Analysis, Tumor Suppressor Protein p53, Tumor Suppressor Proteins, Vidarabine",

author = "Ke Lin and Janet Adamson and Johnson, \{Gillian G\} and Anthony Carter and Melanie Oates and Rachel Wade and Sue Richards and David Gonzalez and Estella Matutes and Claire Dearden and Oscier, \{David G\} and Daniel Catovsky and Pettitt, \{Andrew R\}",

year = "2012",

month = aug,

day = "1",

doi = "10.1158/1078-0432.CCR-11-2936",

language = "English",

volume = "18",

pages = "4191--200",

journal = "Clinical Cancer Research : An Official Journal of the American Association for Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "15",

}

Lin, K, Adamson, J, Johnson, GG, Carter, A, Oates, M, Wade, R, Richards, S, Gonzalez, D, Matutes, E, Dearden, C, Oscier, DG, Catovsky, D & Pettitt, AR 2012, 'Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration', Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, VOL. 18, Numéro 15, p. 4191-200. https://doi.org/10.1158/1078-0432.CCR-11-2936

Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration. / Lin, Ke; Adamson, Janet; Johnson, Gillian G et al.
Dans: Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, Vol 18, Numéro 15, 01.08.2012, p. 4191-200.

Résultats de recherche: Article › Revue par des pairs

TY - JOUR

T1 - Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration

AU - Lin, Ke

AU - Adamson, Janet

AU - Johnson, Gillian G

AU - Carter, Anthony

AU - Oates, Melanie

AU - Wade, Rachel

AU - Richards, Sue

AU - Gonzalez, David

AU - Matutes, Estella

AU - Dearden, Claire

AU - Oscier, David G

AU - Catovsky, Daniel

AU - Pettitt, Andrew R

PY - 2012/8/1

Y1 - 2012/8/1

N2 - This study sought to establish whether functional analysis of the ATM-p53-p21 pathway adds to the information provided by currently available prognostic factors in patients with chronic lymphocytic leukemia (CLL) requiring frontline chemotherapy.

AB - This study sought to establish whether functional analysis of the ATM-p53-p21 pathway adds to the information provided by currently available prognostic factors in patients with chronic lymphocytic leukemia (CLL) requiring frontline chemotherapy.

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Ataxia Telangiectasia Mutated Proteins

KW - Cell Cycle Proteins

KW - Chlorambucil

KW - Cyclin-Dependent Kinase Inhibitor p21

KW - Cyclophosphamide

KW - DNA-Binding Proteins

KW - Female

KW - Flow Cytometry

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell

KW - Leukocytes, Mononuclear

KW - Male

KW - Middle Aged

KW - Mutation

KW - Prognosis

KW - Protein-Serine-Threonine Kinases

KW - Randomized Controlled Trials as Topic

KW - Signal Transduction

KW - Survival Analysis

KW - Tumor Suppressor Protein p53

KW - Tumor Suppressor Proteins

KW - Vidarabine

U2 - 10.1158/1078-0432.CCR-11-2936

DO - 10.1158/1078-0432.CCR-11-2936

M3 - Article

C2 - 22675167

SN - 1078-0432

VL - 18

SP - 4191

EP - 4200

JO - Clinical Cancer Research : An Official Journal of the American Association for Cancer Research

JF - Clinical Cancer Research : An Official Journal of the American Association for Cancer Research

IS - 15

ER -

Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial blockade at the level of p21 is associated with short response duration

Résumé

SDG des Nations Unies

Accès au document

Empreinte digitale

Contient cette citation